Colorectal Disease最新文献_第7页

Tailored resection for persistent extramural vascular invasion in locally advanced rectal cancers. 针对局部晚期直肠癌持续性壁外血管侵犯的定制切除术。

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-12 DOI: 10.1111/codi.17234

Devesh S Ballal, Ankit Sharma, Yogesh Bansod, Suman K Ankathi, Mufaddal Kazi, Ashwin Desouza, Avanish P Saklani

引用次数: 0

Inking outside the box: utility of tattooing in rectal cancer-A video vignette. 突破传统的纹身：纹身在直肠癌中的应用--视频短片。

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-11 DOI: 10.1111/codi.17221

Sujata Sai, Syed Althaf, Ravi Arjunan, Srinivas Chunduri, Pavan Sugoor

引用次数: 0

Recurrence rates after strictureplasty for small bowel Crohn's disease remain high in the era of biologics. 在使用生物制剂的时代，小肠克罗恩病狭窄成形术后的复发率仍然很高。

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-08 DOI: 10.1111/codi.17224

A Nasasra, T E M Morrison, A Luberto, M Carvello, K J Williams, J Davies, A Spinelli, A M Mehta, J H Warusavitarne

{"title":"Recurrence rates after strictureplasty for small bowel Crohn's disease remain high in the era of biologics.","authors":"A Nasasra, T E M Morrison, A Luberto, M Carvello, K J Williams, J Davies, A Spinelli, A M Mehta, J H Warusavitarne","doi":"10.1111/codi.17224","DOIUrl":"https://doi.org/10.1111/codi.17224","url":null,"abstract":"Aim: Despite advancements in therapeutic options for Crohn's disease (CD), strictureplasty is a mainstay bowel-preserving technique for small bowel CD. We sought to audit international practice across three high-volume centres since the widespread use of biologic medication.Methods: A retrospective audit was performed for all strictureplasties undertaken for small bowel CD, over a 15-year period (2006-2021), in three high-volume centres in the United Kingdom and Italy. Primary endpoints were clinical recurrence and reoperation for recurrence.Results: In all, 123 patients were included; 58% were men, 25% smoked and 60% had previous abdominal surgery for CD. Median age was 40 years (interquartile range 30-52 years), mean body mass index 22 (15-31) and median disease duration 138 months (81-255 months). 42% had been treated with biologics preoperatively. In total 338 strictureplasties were performed in 123 patients, with a median of two per patient (interquartile range 1-3). Complications occurred in 35%, with 8% scoring Clavien-Dindo Grade 3. There were no Grade 4/5 complications. Postoperative biologic treatment was administered to 84/123 patients (68.3%). Median follow-up was 54 months. 41/123 patients (33.3%) developed clinical recurrence. Reoperation for recurrent stricturing was performed in 26/123 patients (21%). Clinical recurrence and reoperation rates were significantly higher in patients who continued to smoke after their index surgery.Conclusion: Strictureplasty remains a safe and effective surgical treatment for small bowel CD. Recurrence and reoperation rates remain high, regardless of postoperative biologic therapy. Smoking significantly increases the risk of recurrence.","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study. 直肠癌治疗后的患者报告结果--一项前瞻性全国研究。

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-08 DOI: 10.1111/codi.17231

Kathinka Schmidt Slørdahl, Aina Balto, Marianne Grønlie Guren, Arne Wibe, Hartwig Kørner, Stig Norderval, Ylva Maria Gjelsvik, Tor Åge Myklebust, Inger Kristin Larsen

{"title":"Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study.","authors":"Kathinka Schmidt Slørdahl, Aina Balto, Marianne Grønlie Guren, Arne Wibe, Hartwig Kørner, Stig Norderval, Ylva Maria Gjelsvik, Tor Åge Myklebust, Inger Kristin Larsen","doi":"10.1111/codi.17231","DOIUrl":"10.1111/codi.17231","url":null,"abstract":"Aim: While modern treatment has improved rectal cancer (RC) survival, it can cause late side effects that impact health-related quality of life (HRQoL). The aim of this study was to evaluate HRQoL and late effects 1 year after diagnosis in patients who underwent major resection for Stage I-III RC.Method: All patients with RC registered in the Cancer Registry of Norway between 1 January 2019 and 31 December 2020, aged ≥ 18 years, and a control group without colorectal cancer were invited to participate in the study by answering a questionnaire on HRQoL and late effects. Functional domains and symptoms were compared in different patient groups and between patients and controls.Results: There were 558 patients and 1693 controls eligible for analysis. Response rates were 41% for patients and 23% for controls. Some differences in HRQoL were observed between treatment modalities. Major low anterior resection syndrome (LARS) was prevalent in 60.8% of patients, and was associated with lower functional and higher symptom scores compared with patients with no/minor LARS. Patients with major chronic pain [n = 86 (15.4%)] had significantly lower scores for most of the functional items and higher symptom scores than patients with no/minor chronic pain. Patients had some lower functional scores and several higher symptoms score compared with controls.Conclusion: Patients who suffered from major LARS or major chronic pain had significantly impaired functions and more symptoms beyond change in bowel function and pain, respectively. Identification and treatment of these patient may hopefully be beneficial for their HRQoL.","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A novel application of transanal transection and single-stapled anastomosis in salvage surgery for recurrent low rectal cancer following recent laparoscopic anterior resection: A video vignette. 经肛门横断和单缝合吻合术在近期腹腔镜前切除术后复发低位直肠癌挽救手术中的新应用：视频短片。

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-08 DOI: 10.1111/codi.17237

Akinfemi Akingboye, Donna Zaki, Ilenia Merlini, Alberto Buonanno, Salomone Di Saverio

引用次数: 0

Correction to "[What are the outcomes in patients referred to a tertiary referral center for Crohn's rectovaginal fistula surgery?]". 更正"[转诊至三级转诊中心接受克罗恩病直肠阴道瘘手术的患者疗效如何？］

IF 2.9 3区医学

Colorectal Disease Pub Date : 2024-11-07 DOI: 10.1111/codi.17195

引用次数: 0

Robotic total mesorectal excision for low rectal cancer: Transluminal illumination of the recto-vaginal septum, transanal low rectal dissection and handmade low colorectal anastomosis-A video vignette. 机器人全直肠系膜切除术治疗低位直肠癌：直肠阴道隔的经腔照明、经肛门低位直肠切除术和手工低位结肠直肠吻合术--视频短片。

IF 2.9 3区医学